Cancer Research · i3S Porto
Cancer Research Fellowship at i3S Porto
We fund people, not structures. 100% directly to the bench. In partnership with i3S.
Claudio Sunkel 
Manuel Sobrinho-Simões 
Alexandre Quintanilha 
Nuno Abecasis 
Mário Barbosa 
Rui Andrade Barreira Independent Scientific Jury
Oncology projects selected without interference by researchers of unquestionable merit. Meet the Jury →
The Mission & i3S Partnership
Cancer Research at i3S Porto: 100% Directly to the Bench
«Use what I have to help research. If it saves someone else from going through this, it was worth it.»
Pain turned into science: Luís asked that his money go to research — without intermediaries or administrative overhead, so that others might have a fighting chance.
100% to the Bench. Zero Overhead Costs.
Zero overhead costs. Every donation goes 100% to the research bench.
Fellows & Scientists
Cancer Researchers Funded at i3S Porto
We haven't awarded the first grant yet. The fund is currently being built to finance the first research project.
Support Science
Fund Cancer Research at i3S Porto
Donations eligible for tax benefits via i3S. Become a donor and unlock a direct communication channel with the researchers.
«We turned the loss of Luís into a mission. We created this fund because 100% of donations reach the laboratory bench directly.»
— Rui Andrade Barreira, Founder
✨ Projects selected by the jury
🔒 Secure Payment · Funds processed by i3S
Disponível a 29 de outubro de 2026.
You can change or cancel whenever you want. Every euro has a name.
Glass pockets
Open General Ledger: 100% to the Bench
At launch, we secured the first 4 annual grants. Our goal now is to secure the future: continuity and expansion into new areas of translational oncology at i3S. Join those already with us.
We publish what we receive and where it goes. Every cent is dedicated to research, with zero administrative overhead.
- In
1 recurring contributions since launch.
- Where it went
Awarded on merit by the jury to early-career researchers.
- What changed
Immunotherapy, cancer genomics and computational biology, in progress.
Community Action